Fluorescence has long been used to detect biological targets. As these measurements are becoming more and more quantitative, standards are needed to ensure accuracy and reproducibility.
Fluorescence has long been used to detect biological targets. As these measurements are becoming more and more quantitative, standards are needed to ensure accuracy and reproducibility.
Digital tools, such as building information modeling (BIM) software, improves efficiency for optimizing pharmaceutical facility design.
WHEATON® primary packaging solutions manufactured by SciLabware SciLabware Limited, a company of DWK Life Sciences, is one of the world’s leading manufacturers of high quality primary packaging solutions to the diagnostic and pharmaceutical industries across the globe.
Requirements for virus filtration must be considered in developing continuous downstream processes.
Ensuring the stability of biotherapeutics can be achieved through kinetic models that study aggregation and fragmentation.
This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.
This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.
This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.
This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.
This article demonstrates how qualitative physical attributes testing can be used to characterize soft gel capsule rupture/disintegration during rectal administration.
Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products.
-- Innovations in Tablet Press Technology -- Containment for Tableting: Best Practices -- Direct Tableting a Mixture of a Powder Matrix and API Loaded Pellets
Spectroscopic-based control methods were introduced as equivalent alternative methods, first to a gas chromatographic method to monitor an in-process solvent exchange step and second to a potentiometric titration method to release a process input material for drug substance manufacturing.
Spectroscopic-based control methods were introduced as equivalent alternative methods, first to a gas chromatographic method to monitor an in-process solvent exchange step and second to a potentiometric titration method to release a process input material for drug substance manufacturing.
Spectroscopic-based control methods were introduced as equivalent alternative methods, first to a gas chromatographic method to monitor an in-process solvent exchange step and second to a potentiometric titration method to release a process input material for drug substance manufacturing.
Storage and retrieval methods and the unique requirements found in building codes are crucial considerations.
The challenge of achieving sustained delivery of an active ingredient or nutrient can be achieved with extended-release formulations.
LIGHTHOUSE Instruments introduces new technology for robust headspace data generation and areas of application.
Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.
Quality management requires more effort in a complex supply chain.
Drug developers must understand the complex bioanalytical assays for cell- and gene-therapy drug development programs and ensure that partners have the specialized expertise needed for complex therapeutic classes.
Drug developers must understand the complex bioanalytical assays for cell- and gene-therapy drug development programs and ensure that partners have the specialized expertise needed for complex therapeutic classes.
Drug developers must understand the complex bioanalytical assays for cell- and gene-therapy drug development programs and ensure that partners have the specialized expertise needed for complex therapeutic classes.
Drug developers must understand the complex bioanalytical assays for cell- and gene-therapy drug development programs and ensure that partners have the specialized expertise needed for complex therapeutic classes.
Novel analytical methods may help biologics manufacturers respond to stricter regulations on particulate matter.
Webinar Date/Time: Thu, Jul 20, 2023 11:00 AM EDT